Adipose-derived stem cell treatment for osteoarthritic knees June 21, 2016 Overview Show transcript Overview Jay Smith, M.D., vice chair of Physical Medicine and Rehabilitation at Mayo Clinic, describes a clinical trial to evaluate the safety and efficacy of adipose-derived mesenchymal stromal cell injections as a treatment for patients with osteoarthritic knees. Receive Mayo Clinic news in your inbox. Sign up Related ContentArticleCulture-expanded, adipose-derived mesenchymal stem cells tested as treatment for knee osteoarthritis Q and AGene therapy for knee osteoarthritis: Q and A with Christopher H. Evans, Ph.D.ArticleMayo researchers prepare to launch clinical trial using gene therapy for knee osteoarthritis VID-20433303 Medical Professionals Adipose-Derived Stem Cell Treatment for Osteoarthritic Knees